CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 53 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $3,375,000 | +49.7% | 730,557 | +26.7% | 0.32% | +19.6% |
Q4 2017 | $2,255,000 | +112.9% | 576,825 | -36.3% | 0.26% | +15.2% |
Q1 2016 | $1,059,000 | -70.3% | 905,000 | -37.8% | 0.23% | -55.9% |
Q4 2015 | $3,565,000 | +8.0% | 1,455,000 | +32.3% | 0.52% | +24.0% |
Q3 2015 | $3,300,000 | -33.4% | 1,100,000 | -8.3% | 0.42% | -13.2% |
Q2 2015 | $4,956,000 | +4.1% | 1,200,000 | +9.1% | 0.48% | -2.2% |
Q1 2015 | $4,763,000 | +51.3% | 1,100,000 | +3.8% | 0.50% | -7.5% |
Q4 2014 | $3,148,000 | +38.3% | 1,060,000 | +54.6% | 0.54% | +90.7% |
Q3 2014 | $2,276,000 | – | 685,500 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |